Irritable bowel syndrome patients show altered sensitivity to exogenous opioids

Pain

Volumn 87, Issue 2, 2000, Pages 137-147

  Lembo, Tony ^a   Naliboff, Bruce D ^b,c   Matin, Kamran ^c   Munakata, Julie ^c   Parker, Robert A ^a   Gracely, Richard H ^d   Mayer, Emeran A ^c,e  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antinociception; Fentanyl; Visceral pain

Indexed keywords

FENTANYL; MU OPIATE RECEPTOR AGONIST; NARCOTIC ANALGESIC AGENT; SODIUM CHLORIDE;

ADULT; ANTINOCICEPTION; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; COLON DILATATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SENSITIVITY; FATIGUE; FEMALE; HEADACHE; HUMAN; IRRITABLE COLON; MALE; NOCICEPTION; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PERCEPTIVE THRESHOLD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VISCERAL PAIN;

ADULT; ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; COLONIC DISEASES, FUNCTIONAL; FEMALE; FENTANYL; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PAIN THRESHOLD; RECEPTORS, OPIOID, MU; RECTUM;

EID: 0034255384     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(00)00282-7     Document Type: Article

References (45)

1. Adler L.J., Gyulai F.E., Diehl D.J., Mintun M.A., Winter P.M., Firestone L.L. Regional brain activity associated with fentanyl analgesia elucidated by positron emission tomography. Anesth Analg. 84:1997;120-126.
2. Aggarwal A., Cutts T.F., Abell T.L., Cardoso S., Familoni B., Bremer J., Karas J. Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities. Gastroenterology. 106:1994;945-950.
3. Atweh S.F., Kuhar M.J. Distribution and physiological significance of opioid receptors in the brain. Br Med Bull. 39:1983;47-52.
4. Burks T.F., Fox D.A., Hirning L.D., Shook J.E., Porreca F. Regulation of gastrointestinal function by multiple opioid receptors. Life Sci. 43:1988;2177-2181.
5. Chang L., Munakata J., Mayer E.A., Schmulson M.J., Bernstein C.N., Saba L., Naliboff B., Anton P.A., Matin K. Perceptual responses in patients with inflammatory and functional bowel disease. Gut. 2000;. in press.
6. Delvaux M.M., Louvel D., Lagier E., Scherrer B., Abitbol J.L., Frexinos J. The kappa agonist fedotozine relieves hypersensitivity to colonic distension in patients with irritable bowel syndrome. Gastroenterology. 116:1999;38-45.
7. Devinsky O., Morrell M.J., Vogt B.A. Contributions of anterior cingulate cortex to behaviour. Brain. 118:1995;279-306.
8. Esler M.D., Goulston K.J. Levels of anxiety in colonic disorders. N Engl J Med. 288:1973;16-20.
9. Fields H.L., Heinricher M.M., Mason P. Neurotransmitters in nociceptive modulatory circuits. Annu Rev Neurosci. 14:1991;219-245.
10. Gracely R.H., Naliboff B. Measurement of pain sensation. Kruger L. Pain and touch. 1996;244-313 Academic Press, San Diego, CA.
11. Gracely R.H., McGrath P., Dubner R. Ratio scales of sensory and affective verbal pain descriptors. Pain. 5:1978;5-18.
12. Heitkemper M., Jarrett M., Bond E., Walker E., Rockwell M. Increased sympathetic nervous system activity in women with IBS. Am Gastroenterol Assoc. 106:1994;A509.
13. Holstege G. Some anatomical observations on the projections from the hypothalamus to brainstem and spinal cord: an HRP and autoradiographic tracing study in the cat. J Comp Neurol. 260:1987;98-126.
14. Jones A.K.P., Friston K.J., Qi L.Y., Harris M., Cunningham V.J., Jones T., Feinman C., Frackowiak R.S. Sites of action of morphine in the brain. Lancet. 338:1991;825.
15. Jones A.K.P., Qi L., Cunningham V.V., Brown D.W., Ha-Kawa S.L., Fujiwara T., Friston K.F., Silva S., Luthra S.K., Jones T. Endogenous opiate response to pain in rheumatoid arthritis and cortical and subcortical response to pain in normal volunteers using positron emission tomography. Int J Clin Pharmacol Res. 11:1991;261-266.
16. Kamath M.V., Fallen E.L. Power spectral analysis of heart rate variability: a noninvasive signature of cardiac autonomic function. Crit Rev Biomed Eng. 21:1993;245-311.
17. Karling P., Nyhlin H., Wiklund U., Sjoberg M., Olofsson B.-O., Bjerle P. Spectral analysis of heart rate variability in patients with irritable bowel syndrome. Scand J Gastroenterol. 33:1998;572-576.
18. Kaufman P.N., Krevsky B., Malmud L.S., Maurer A.H., Somers M.B., Siegal J.A., Fisher R.S. Role of opiate receptors in the regulation of colonic transit. Gastroenterol Int. 94:(6):1988;1351-1356.
19. Keay K.A., Crowfoot L.J., Floyd N.S., Henderson L.A., Christie M.J., Bandler R. Cardiovascular effects of microinjections of opioid agonists into the 'depressor region' of the ventrolateral periaqueducral gray region. Brain Res. 762:1997;61-71.
20. Lembo T., Munakata J., Mertz H., Niazi N., Kodner A., Nikas V., Mayer E. Evidence for the hypersensitivity of lumbar splanchnic afferents in irritable bowel syndrome. Gastroenterology. 107:1994;1686-1696.
21. Lipkin M., Sleisenger M.H. Studies of visceral pain: measurements of stimulus intensity and duration associated with the onset of pain in esophagus, ileum and colon. J Cancer Inst. 37:1957;28-34.
22. Loewy A.D. Holstege G. Forebrain nuclei involved in autonomic control. 1991;253-268.
23. Maguire P., Tsai N., Kamal J., Cometta-Morini C., Upton C., Loew G. Pharmacological profiles of fentanyl analogs at mu, delta and kappa opiate receptors. Eur J Pharmacol. 213:1992;219-225.
24. Manning B.H. A lateralized deficit in morphine antinociception after unilateral inactivation of the central amygdala. J Neurosci. 2000;. in press.
25. Manning A.P., Thompson W.D., Heaton K.W., Morris A.F. Towards positive diagnosis in the irritable bowel syndrome. Br Med J. 2:1978;653-654.
26. Matthes H.W., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dolle P., Tzavara E., Hanoune J., Roques B.P., Keiffer B.L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature. 383:1996;819-823.
27. Mayer E.A., Gebhart G.F. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology. 107:1994;271-293.
28. Mayer E.A., Liu M., Munakata J., Mandelkern M., Berman S., Silverman D.H.S., Schmulson M., Williams J., Kovalik E., Naliboff B. Regional brain activity before and after visceral sensitization (abstract). Soc Neurosci Abstr. 24:1998;529.
29. McEnvoy G.K. Fentanyl citrate. McEnvoy G.K. AHFS drug information. 1999;1782-1786 American Society of Health System Pharmacology, Bethesda, MD.
30. Mertz H., Naliboff B., Munakata J., Niazi N., Mayer E.A. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology. 109:1995;40-52.
31. Mogil J.S., Kest B., Sadowski B., Belknap J.K. Differential genetic mediation of sensitivity to morphine in genetic models of opiate antinociception: influence of nociceptive assay. J Pharmacol Exp Ther. 276:1996;532-544.
32. Mogil J.S., Sternberg W.F., Marek P., Sadowski B., Belknap J.K., Liebeskind J.C. The genetics of pain and pain inhibition. Proc Natl Acad Sci USA. 93:1996;3048-3055.
33. Munakata J., Naliboff B., Harraf F., Kodner A., Lembo T., Chang L., Silverman D.H., Mayer E.A. Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome. Gastroenterology. 112:1997;55-63.
34. Munakata J., Mayer E.A., Chang L., Schmulson M., Liu M., Tougas G., Kamath M., Naliboff B. Autonomic and neuroendocrine responses to recto-sigmoid stimulation (abstract). Gastroenterology. 114:1998;808.
35. Naliboff B.D., Munakata J., Fullerton S., Gracely R.H., Kodner A., Harraf F., Mayer E.A. Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut. 41:1997;505-512.
36. Naliboff B.D., Munakata J., Chang L., Mayer E.A. Toward a biobehavioral model of visceral hypersensitivity in irritable bowel syndrome. J Psychosom Res. 45:1998;485-492.
37. Pfeiffer A., Pasi A., Mehraein P., Herz A. Opiate receptor binding sites in human brain. Brain Res. 248:1982;87-96.
38. Schang J.C., Hemond M., Hebert M., Pilote M. How does morphine work on colonic motility? An electromyographic study in the human left and sigmoid colon. Life Sci. 38:1986;671-676.
39. Silverman D.H., Munakata J.A., Ennes H., Mandelkern M.A., Hoh C.K., Mayer E.A. Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology. 112:1997;64-72.
40. Simon E.J., Hiller J.M. The opiate receptors. Annu Rev Pharmacol Toxicol. 18:1978;371-394.
41. Steadman C.J., Phillips S.F., Camilleri M., Talley N.J., Haddad A., Hanson R. Control of muscle tone in the human colon. Gut. 33:(4):1992;541-546.
42. Thompson W.G., Creed F., Drossman D.A., Heaton K.W., Mazzacca G. Functional bowel disease and functional abdominal pain. Gastroenterol Int. 5:1992;75-91.
43. Vogt B.A., Watanabe H., Grootoonk S., Jones A.K.P. Topography of diprenorphine binding in human cingulate gyrus and adjacent cortex derived from coregistered PET and MR images. Human Brain Mapping. 3:1995;1-12.
44. Warmsley J.K., Zarbin M.A., Young W.S., Kuhar M.J. Distribution of opiate receptors in the monkey brain: an autoradiography study. Neuroscience. 7:1982;595-613.
45. Wei F., Dubner R., Ren K. Nucleus reticularis gigantocellularis and nucleus raphe magnus in the brain stem exert opposite effects on behavioral hyperalgesia and spinal Fos protein expression after peripheral inflammation. Pain. 80:1999;127-141.